Peter Gowland

559 total citations
36 papers, 404 citations indexed

About

Peter Gowland is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Peter Gowland has authored 36 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 10 papers in Epidemiology and 8 papers in Hepatology. Recurrent topics in Peter Gowland's work include Hepatitis B Virus Studies (9 papers), HIV Research and Treatment (7 papers) and Blood groups and transfusion (7 papers). Peter Gowland is often cited by papers focused on Hepatitis B Virus Studies (9 papers), HIV Research and Treatment (7 papers) and Blood groups and transfusion (7 papers). Peter Gowland collaborates with scholars based in Switzerland, Germany and United States. Peter Gowland's co-authors include Christoph Niederhauser, Stefano Fontana, Caroline Tinguely, Behrouz Mansouri Taleghani, Hein Hustinx, Florian Strasser, Christian Ruef, Richard W. Cone, Raffaele Bruno and Milos Opravil and has published in prestigious journals such as Methods in enzymology on CD-ROM/Methods in enzymology, The Journal of Infectious Diseases and AIDS.

In The Last Decade

Peter Gowland

33 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Gowland Switzerland 12 160 114 111 109 81 36 404
DB Brettler United States 9 68 0.4× 153 1.3× 137 1.2× 225 2.1× 73 0.9× 14 566
FA Bontempo United States 8 67 0.4× 126 1.1× 121 1.1× 203 1.9× 71 0.9× 12 384
A. M. J. Wensing Netherlands 11 187 1.2× 163 1.4× 70 0.6× 29 0.3× 169 2.1× 22 442
J.J. Fournel France 10 57 0.4× 215 1.9× 158 1.4× 111 1.0× 138 1.7× 17 462
Janice M. Darden United States 8 121 0.8× 67 0.6× 12 0.1× 31 0.3× 154 1.9× 16 349
Lefrère Jj France 9 159 1.0× 96 0.8× 48 0.4× 58 0.5× 18 0.2× 32 306
Jessica Markby Switzerland 11 194 1.2× 135 1.2× 65 0.6× 19 0.2× 102 1.3× 28 589
Laura Tarancón‐Díez Spain 11 121 0.8× 78 0.7× 34 0.3× 48 0.4× 169 2.1× 42 388
C. Rabian France 10 70 0.4× 79 0.7× 21 0.2× 51 0.5× 50 0.6× 15 345
H Weigel Netherlands 11 150 0.9× 73 0.6× 13 0.1× 38 0.3× 136 1.7× 15 331

Countries citing papers authored by Peter Gowland

Since Specialization
Citations

This map shows the geographic impact of Peter Gowland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gowland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gowland more than expected).

Fields of papers citing papers by Peter Gowland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Gowland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gowland. The network helps show where Peter Gowland may publish in the future.

Co-authorship network of co-authors of Peter Gowland

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Gowland. A scholar is included among the top collaborators of Peter Gowland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Gowland. Peter Gowland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solari, Daria, Mauro Serricchio, Maddalena Motta, et al.. (2025). Parvovirus B19 Infection after Transfusion of a Pathogen-Reduced Platelet Concentrate: A Case Report. Transfusion Medicine and Hemotherapy. 53(1). 44–49.
2.
Serricchio, Mauro, Peter Gowland, Sophie Waldvogel, et al.. (2025). Surveillance of blood donors detects an exceptional Parvovirus B19 outbreak in Switzerland in 2023/2024.. PubMed. 23(6). 515–522. 1 indexed citations
3.
Niederhauser, Christoph, Caroline Tinguely, Stefano Fontana, et al.. (2025). Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors. Viruses. 17(10). 1292–1292.
4.
Serricchio, Mauro, et al.. (2024). HEV in Blood Donors in Switzerland: The Route to Safe Blood Products. Pathogens. 13(10). 911–911. 1 indexed citations
5.
Ripellino, Paolo, et al.. (2023). Epidemiology of HEV Infection in Blood Donors in Southern Switzerland. Microorganisms. 11(10). 2375–2375. 5 indexed citations
6.
Sendi, Parham, Mattia Branca, Manuel R. Blum, et al.. (2023). Do quantitative levels of antispike‐IgG antibodies aid in predicting protection from SARS‐CoV‐2 infection? Results from a longitudinal study in a police cohort. Journal of Medical Virology. 95(7). e28904–e28904. 4 indexed citations
7.
Ackermann‐Gäumann, Rahel, Peter Gowland, Caroline Tinguely, et al.. (2023). Prevalence of anti-tick-borne encephalitis virus (TBEV) antibodies in Swiss blood donors in 2014-2015.. PubMed. 21(2). 100–109. 5 indexed citations
8.
Sendi, Parham, Rossella Baldan, Peter Gowland, et al.. (2021). A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study. Open Forum Infectious Diseases. 8(12). ofab524–ofab524. 3 indexed citations
9.
Niederhauser, Christoph, Caroline Tinguely, J Dreier, et al.. (2021). Comparison of a New IgG-EIA for the Detection of Anti-Plasmodium Antibodies with Two Currently Used Assays. Transfusion Medicine and Hemotherapy. 48(5). 265–271. 6 indexed citations
10.
Gowland, Peter, et al.. (2019). Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country. Transfusion Medicine and Hemotherapy. 46(2). 104–110. 6 indexed citations
11.
Gowland, Peter, et al.. (2016). Parvovirus B19 Passive Transmission by Transfusion of Intercept® Blood System-Treated Platelet Concentrate. Transfusion Medicine and Hemotherapy. 43(3). 198–202. 16 indexed citations
12.
Meyer, Stefan, Jochen Gottschalk, Behrouz Mansouri Taleghani, et al.. (2014). Implementation of a mandatory donor RHD screening in Switzerland. Transfusion and Apheresis Science. 50(2). 169–174. 31 indexed citations
13.
Gowland, Peter, Christoph Gassner, Hein Hustinx, et al.. (2014). Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors. Transfusion and Apheresis Science. 50(2). 163–168. 16 indexed citations
14.
Tinguely, Caroline, Stefano Fontana, Peter Gowland, et al.. (2010). Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion‐transmitted hepatitis B virus infection in Switzerland, a low‐endemic region. Transfusion. 50(12). 2695–2706. 24 indexed citations
15.
Hustinx, Hein, Stefano Fontana, Peter Gowland, & Christoph Niederhauser. (2009). Will Genotyping Replace Serology in Future Routine Blood Grouping? – Opinion 2. Transfusion Medicine and Hemotherapy. 36(3). 228–229. 4 indexed citations
16.
Hustinx, Hein, Joyce Poole, Peter Bugert, et al.. (2008). Molecular basis of the Rh antigen RH48 (JAL). Vox Sanguinis. 96(3). 234–239. 9 indexed citations
17.
Flegel, Willy A., Nicole I. Eicher, Andrea Doescher, et al.. (2006). In‐frame triplet deletions inRHDalter the D antigen phenotype. Transfusion. 46(12). 2156–2161. 17 indexed citations
18.
Gowland, Peter, et al.. (2004). Molecular and serologic tracing of a transfusion‐transmitted hepatitis A virus. Transfusion. 44(11). 1555–1561. 31 indexed citations
19.
20.
Günthard, Huldrych F., Peter Gowland, Jörg Schüpbach, et al.. (1994). A Phase I/IIA Clinical Study With A Chimeric Mouse-Human Monoclonal Antibody To The V3 Loop Of Human Immunodeficiency Virus Type 1 Gp120. The Journal of Infectious Diseases. 170(6). 1384–1393. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DB Brettler Breakdown of academic impact, for papers by FA Bontempo Breakdown of academic impact, for papers by A. M. J. Wensing Breakdown of academic impact, for papers by J.J. Fournel Breakdown of academic impact, for papers by Janice M. Darden Breakdown of academic impact, for papers by Lefrère Jj Breakdown of academic impact, for papers by Jessica Markby Breakdown of academic impact, for papers by Laura Tarancón‐Díez Breakdown of academic impact, for papers by C. Rabian Breakdown of academic impact, for papers by H Weigel
Rankless by CCL
2026